The drug targets the PCSK9 protein, and could give millions of people a more affordable option to reduce their heart disease ...

One dose of an experimental drug cover offer lifetime treatment for people with high cholesterol, but its long-term safety is ...

An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers ...

An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...

OCEAN was an open-label trial conducted in Australia, Belgium, Canada, China, Germany, and Israel. Eligible participants had ...

NEW ORLEANS – A single injection of a gene-edited protein was deemed productive and safe in patients with dyslipidemia that ...

Disruptions to the body's internal clock are strongly associated with increased risk of obesity, diabetes, high blood ...

A recent study links long-term melatonin use to a higher risk of heart failure and death. Researchers analyzed health records ...

For some people with high cholesterol, making lifestyle changes and taking routine cholesterol-lowering statin medications ...

Researchers are learning a great deal more about how heart health later in life heavily depends on the habits built during ...

The Mobile Heart Walk was held Saturday morning on campus. Dozens of people gathered on the campus for the event. Fox Ten is the media sponsor and Lenise Ligon and other FOX 10 staff members were on ...

CRISPR Therapeutics' CEO said he hoped to have a product on the market in the next four or five years. Read more at ...